全文获取类型
收费全文 | 78篇 |
免费 | 6篇 |
出版年
2023年 | 2篇 |
2021年 | 2篇 |
2020年 | 1篇 |
2019年 | 2篇 |
2018年 | 1篇 |
2017年 | 6篇 |
2016年 | 3篇 |
2015年 | 2篇 |
2014年 | 5篇 |
2013年 | 3篇 |
2012年 | 7篇 |
2011年 | 6篇 |
2010年 | 1篇 |
2008年 | 5篇 |
2007年 | 4篇 |
2006年 | 6篇 |
2005年 | 2篇 |
2004年 | 3篇 |
2003年 | 4篇 |
2002年 | 1篇 |
2001年 | 1篇 |
2000年 | 2篇 |
1998年 | 2篇 |
1997年 | 2篇 |
1989年 | 1篇 |
1988年 | 1篇 |
1987年 | 1篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1981年 | 1篇 |
1974年 | 2篇 |
1973年 | 1篇 |
1971年 | 2篇 |
排序方式: 共有84条查询结果,搜索用时 0 毫秒
81.
Saute JA da Silveira LE Soares FA Martini LH Souza DO Ganzella M 《Neurobiology of learning and memory》2006,85(3):206-212
Extracellular guanine-based purines, namely the nucleotides GTP, GDP, GMP and the nucleoside guanosine, exert important neuroprotective and neuromodulator roles in the central nervous system, which may be related to inhibition of the glutamatergic neurotransmission activity. In this study, we investigated GMP effects on mice inhibitory avoidance performance and the dependence on its conversion to guanosine for such effect, by using the ecto-5'-nucleotidase specific inhibitor AOPCP. We also investigated if this conversion occurs in the central nervous system or peripherally, and if guanosine and GMP affect nociception by the tail-flick test. I.p. GMP or guanosine (7.5 mg/kg) or i.c.v. GMP (480 nmol) pretraining administration was amnesic for the inhibitory avoidance task. I.c.v. AOPCP (1 nmol) administration completely reversed the amnesic effect of i.c.v. GMP, but not of i.p. GMP, indicating that peripheral conversion of GMP to guanosine is probably relevant to this effect. AOPCP alone did not interfere with the performance. Furthermore, tail-flick measurement was unaffected by i.p. GMP and guanosine, suggesting that the amnesic effect of both purines was not due to some antinociceptive effect against the footshock used in the task. All these data together, in accordance to those previously observed in studies involving glutamate uptake and seizures reinforce the idea that guanosine is the specific extracellular guanine-based purines effector and indicate that its conversion occurs not only in the central nervous system but also peripherally. 相似文献
82.
Marcelo Alejandro Falappa Alejandro Javier García Gabriele Kern-Isberner Guillermo Ricardo Simari 《Journal of Philosophical Logic》2013,42(1):161-193
We propose a revision operator on a stratified belief base, i.e., a belief base that stores beliefs in different strata corresponding to the value an agent assigns to these beliefs. Furthermore, the operator will be defined as to perform the revision in such a way that information is never lost upon revision but stored in a stratum or layer containing information perceived as having a lower value. In this manner, if the revision of one layer leads to the rejection of some information to maintain consistency, instead of being withdrawn it will be kept and introduced in a different layer with lower value. Throughout this development we will follow the principle of minimal change, being one of the important principles proposed in belief change theory, particularly emphasized in the AGM model. Regarding the reasoning part from the stratified belief base, the agent will obtain the inferences using an argumentative formalism. Thus, the argumentation framework will decide which information prevails when sentences of different layers are used for entailing conflicting beliefs. We will also illustrate how inferences are changed and how the status of arguments can be modified after a revision process. 相似文献
83.
84.
Berthier ML Pulvermüller F Dávila G Casares NG Gutiérrez A 《Neuropsychology review》2011,21(3):302-317
This review considers the role of drug therapy in the treatment of post-stroke aphasia, the evidence for efficacy of different
agents, and the theory-based explanations of drug-related benefits for aphasia rehabilitation. Pharmacological interventions
modulating stroke-induced disruption of diverse neurotransmitters may improve language and communication deficits in aphasic
patients through facilitation of brain plasticity and long-term potentiation. However, benefits are not evident for all compounds
and refinement in clinical trial designs is required. Some pharmacological trials have failed because drug treatment was not
combined with speech-language therapy, while other trials combining drugs with intensive model-driven therapies also failed
probably because of short-trial duration, inadequate sample selection, or lack of drug action. Preliminary data reveals that
combining neuroscience-based intensive aphasia techniques (constraint-induced aphasia therapy) and drugs acting on cholinergic
and glutamatergic neurotransmitter systems are associated with better outcomes than other strategies and long-term maintenance
of benefits. Although further studies are needed, current state of the evidence suggests that drug therapy may play a key
role in the treatment of post-stroke aphasia. 相似文献